Oxford University scientists and colleagues have used Diamond’s ‘super microscopes’ to build a complete picture of HsaD: a protein that enables the tuberculosis bacteria to survive in the human body. Understanding the three-dimensional structure of the protein will help in the development of drugs to treat the disease.
Tuberculosis is the leading cause of death from an infectious agent worldwide, killing over 1.5 million people every year. Dr Isaac Westwood, a member of the Oxford team investigating HsaD, said: ‘It is only by continued collaborative and multidisciplinary research that we can gain a better understanding of this important pathogen, and to develop novel therapies to treat tuberculosis. New therapies are desperately needed, with increased incidence worldwide of multi- and extensively-drug resistant strains of Mycobacterium tuberculosis.’
A report of the research, published in a recent edition of Acta Crystallographica, describes how the scientists studying the genetic make-up of Mycobacterium tuberculosis, identified genes that enable it to survive within human cells. One of the genes encodes for HsaD, a protein that acts as a catalyst in the metabolism of cholesterol. The researchers then used the Diamond synchrotron to determine HsaD’s three-dimensional protein structure by X-ray crystallography.
‘Our research is the first step towards a detailed understanding of how the HsaD enzyme is involved in the pathogenicity and persistence of M. tuberculosis, commented Dr Westwood. ‘It is also the first step in the rational drug design process: where we can design potential drugs based on the 3D structure of essential biological molecules. The HsaD enzyme is one of several related enzymes which we are actively investigating as new targets against M. tuberculosis.’
‘This research will give vital information about a novel biochemical pathway in this organism, and also may lead to the development of new therapies which help to control the tuberculosis epidemic.’
The teams involved at Oxford University were in Pharmacology (Mr Nathan Lack, Dr Isaac Westwood, Professor Edith Sim) and Molecular Biophysics (Dr Ed Lowe, Professor Martin Noble), in collaboration with Dr Jie Liu and Professor Lindsay Eltis at the University of British Columbia in Vancouver.
Source: Oxford University
Related stories:
New drug to stop tuberculosis epidemic
Researchers at the University of Manchester are developing a new drug against tuberculosis (TB), one of the oldest human infectious diseases, which is now threatening to reach epidemic proportions once more.
Vancouver researchers discover missing link between TB bacteria and humans
Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered how tuberculosis (TB) bacteria hide and multiply in the human body and are working toward a treatment to block this mechanism of infection.
Biochips can detect cancers before symptoms develop
In their fight against cancer, doctors have just gained an impressive new weapon to add to their arsenal. Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic.
Glowing sugars light up zebrafish
Using artificial sugar and some clever chemistry, University of California, Berkeley, researchers have made glow-in-the-dark fish whose internal light comes from the sugar coating on their cells.
Toward a new generation of vaccines for malaria and other diseases
Researchers in Colombia, South America, describe a new strategy for designing the next generation of synthetic vaccines that could lead to more effective treatments for fighting malaria, tuberculosis, AIDS and other infectious diseases. These conditions kill more than 17 million people around the world each year. Their study appears in the current issue of ACS’
Accounts of Chemical Research.
Scientists discover how TB 'develops invincibility' against only available treatment
Scientists at the University of Leicester have uncovered a dramatic new twist in the battle against TB. They have identified how the killer bacterium makes itself immune to a key component of the only effective treatment against the disease.
Researchers crack code of 3-D structure in key metabolic protein
Using X-ray crystallography, researchers at the University of Pittsburgh School of Medicine led by structural biologist Joanne I. Yeh, Ph.D., have become the first to decipher the three-dimensional structure of a membrane-bound enzyme that plays a crucial role in glycerol metabolism – a discovery that could lead to important advances against obesity, diabetes and a potential host of other diseases. Their findings are reported in the March 4 issue of the
Proceedings of the National Academy of Sciences.
New TB test means quicker and easier diagnosis for patients
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal
Annals of Internal Medicine.
